SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED
SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED is a GUJARAT based PRIVATE LIMITED company, Registered at dated 16-FEB-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED is U46497GJ2024PTC148746 and registration number is 148746.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC AHMEDABAD India. Authorized share capital of SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED has 2 directors ANITA SHAHBAZ, BHAGIRATH SINGH,
The registered Email address of SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED is as9910303533@gmail.com and its registered address is TF/27 SITARAM SUPERMARKET CHHANI TA BARODA CHHANI (VADODARA) VADODARA VADODARA GJ 391740 IN GUJARAT GUJARAT india 391740.
The current status of SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
SOLBRILLANT PHARMACEUTICALS PRIVATE LIMITED
ROC AHMEDABAD
ACTIVE
U46497GJ2024PTC148746
16-FEB-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
391740
INDIA
TF/27 SITARAM SUPERMARKET CHHANI TA BARODA CHHANI (VADODARA) VADODARA VADODARA GJ 391740 IN
as9910303533@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
06755697 | ANITA SHAHBAZ | Director | 16/02/2024 |
08400077 | BHAGIRATH SINGH | Director | 16/02/2024 |
Details Updated by Companies
Quick Links
- All Registered company of GUJARAT
- Company Registered in GUJARAT
- All Registered company of VADODARA in GUJARAT
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.